<PAGE>
================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 15, 1998
-----------------------
VENCOR, INC.
(Exact name of registrant as specified in its charter)
Delaware 001-14057 61-1323993
(State or other jurisdiction of (Commission File Number) (IRS Employer
incorporation or organization) Identification No.)
3300 Aegon Center
400 West Market Street
Louisville, Kentucky
(Address of principal executive offices)
40202
(Zip Code)
Registrant's telephone number, including area code: (502) 596-7300
Not Applicable
(Former name or former address, if changed since last report.)
================================================================================
<PAGE>
ITEMS 1-4. NOT APPLICABLE.
ITEM 5. OTHER INFORMATION.
On July 15, 1998, Vencor, Inc. (the "Company") announced revised earnings
expectations for the three month period ended June 30, 1998. A copy of the press
release is included as an exhibit to this filing and is incorporated herein by
reference.
The above statements include forward-looking statements, particularly with
respect to future financial results. However, actual results could differ
materially from projections contained in these forward-looking statements. The
Company cautions investors that any forward-looking statements are not
guarantees of future performance. Numerous factors exist which, in some cases
have affected, and in the future could cause results to differ materially from
these expectations. These statements involve risks and uncertainties concerning
the Company's business strategy addressing healthcare regulatory changes, its
recent reorganization and increased debt structure and other factors detailed in
the Company's Form 10 and in the Company's other filings with the Securities and
Exchange Commission.
ITEM 6. NOT APPLICABLE.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial statements of businesses acquired.
Not applicable.
(b) Pro forma financial information.
Not applicable.
(c) Exhibits.
Exhibit 99.1 Press Release dated July 15, 1998 announcing revised
earnings expectations for the three month period ended June 30, 1998.
ITEMS 8-9. NOT APPLICABLE.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
VENCOR, INC.
Dated: July 16, 1998 By: /s/ W. Earl Reed, III
---------------------
W. Earl Reed, III
Executive Vice President
and Chief Financial Officer
3
<PAGE>
Exhibit 99.1
[Logo of Vencor, Inc. appears here]
CONTACT: W. Earl Reed, III
Executive Vice President and
Chief Financial Officer
(502) 596-7380
FOR IMMEDIATE RELEASE
- ---------------------
VENCOR REVISES SECOND QUARTER EARNINGS EXPECTATIONS
LOUISVILLE, Ky. (July 15, 1998) - Vencor, Inc. (NYSE: VC) today announced that
it expects second quarter earnings to be below expectations based on preliminary
information. Excluding one-time charges, the Company expects to report a loss
between $0.10 to $0.15 per share on a pro forma basis for the three month period
ended June 30, 1998. The Company expects to report second quarter results on
July 28, 1998.
Vencor is a long-term healthcare provider operating hospitals, nursing
centers and contract ancillary services in 45 states.
The above statements include forward-looking statements, particularly with
respect to future financial results. However, actual results could differ
materially from projections contained in these forward-looking statements. The
Company cautions investors that any forward-looking statements are not
guarantees of future performance. Numerous factors exist which, in some cases
have affected, and in the future could cause results to differ materially from
these expectations. These statements involve risks and uncertainties concerning
the Company's business strategy addressing healthcare regulatory changes, its
recent reorganization and increased debt structure and other factors detailed in
the Company's Form 10 and in the Company's other filings with the Securities and
Exchange Commission.
